Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

All-Diabetes Pro-Cycling Team Race Across UK to Inspire Diabetes Community


News provided by

Novo Nordisk

07 Sep, 2015, 07:00 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Team Novo Nordisk, the world's first all-diabetes pro-cycling team, are racing across the UK to empower, educate and inspire the diabetes community (PRNewsFoto/Novo Nordisk) (PRNewsFoto/Novo Nordisk)

BRIGHTON, England, September 7, 2015 /PRNewswire/ --

Team Novo Nordisk, the first all-diabetes professional cycling team, saddle up today to compete in the UK's leading professional cycle race. This unique team of cyclists all have type 1 diabetes and manage their condition while competing in one of the toughest endurance sports. 

Racing in the prestigious Tour of Britain, Team Novo Nordisk are hoping to inspire, educate and empower those across the UK who are affected by diabetes.

     (Photo: http://photos.prnewswire.com/prnh/20150904/263930 )

In the UK, there are approximately 3.9 million people living with diabetes, and the number is increasing-every two minutes, another person receives a diabetes diagnosis.[1] The NHS spends 10% of its yearly budget on managing diabetes-this amounts to £1 million every hour.[2]

Phil Southerland, co-founder and CEO of Team Novo Nordisk says: "We are thrilled to be competing in the UK again this year. When diagnosed with diabetes, many people think it means they won't be able to live life the way they'd hoped. We're here to show people with diabetes that you can achieve your goals and live life well through good control. That's exactly what we're doing in the UK, with the men's professional cycling team and elsewhere with our wider team; including the youngsters in our development team."

During the Tour, Team Novo Nordisk will begin in Wales and race across the country, riding through towns and cities including Edinburgh, Stoke on Trent and Ipswich, before competing in the final London stage on the 13th September. Fans are encouraged to join Team Novo Nordisk at any stage of the race to show their support.

Karen Addington, Chief Executive in the UK for type 1 diabetes charity JDRF, said: "Team Novo Nordisk is inspiring people with diabetes of all ages. Exercise, monitoring and appropriate treatment is important in the management of both types 1 and 2 diabetes. The team's success shows what's possible when living with the condition - diabetes never has to hold you back in life. Daily self-management of the condition is certainly a challenge. But in embracing this challenge, you can still go on to achieve great things."

Details of the Tour of Britain race stages can be found at http://www.tourofbritain.co.uk/stages.

Novo Nordisk A/S is the primary sponsor of Team Novo Nordisk 

Notes to Editors: 

Available for interview:  

  • Phil Southerland, co-founder and CEO of Team Novo Nordisk
  • UK development team riders-Chris McGovern, 19, from Epsom, and Gavin Alexander, 19, from Glasgow
  • Diabetes case studies-Steve Mitchell, 53, (type 2 diabetes) and his son Nathan, 18, (type 1 diabetes) from Preston, Lancashire

More information about the team can be found by visiting http://www.teamnovonordisk.com, following the Team @teamnovonordisk on Twitter, or liking the Team Novo Nordisk Facebook page*.

*Novo Nordisk is not responsible for the content of these websites and social media channels.

About Phil Southerland and Team Novo Nordisk  

Team Novo Nordisk is a global all-diabetes sports team of cyclists, triathletes and runners who live with diabetes, spearheaded by the professional cycling team. Most members of the team were diagnosed before the age of 18, and act as inspirational role models to young people with diabetes, showing what can be achieved while maintaining good diabetes control.

Phil Southerland, co-founder and CEO of Team Novo Nordisk was diagnosed with type 1 diabetes at just seven months old. He began cycling at the age of 12, and climbed through the ranks of junior competitions. In 2007, Phil competed, along with his teammates, in the 3,000 mile Race Across America-a race which the team went on to win.

He has since combined his passion for the sport and his mission of redefining the boundaries for those living with diabetes by forming Team Novo Nordisk, and becoming a global ambassador for diabetes, educating and empowering people with diabetes across the world.

The Team Novo Nordisk pro-cycling team competed in its first International Cycling Union (UCI) race in 2013, and includes 18 riders from around the world. Team Novo Nordisk is part of the Changing Diabetes® initiative, the Novo Nordisk global commitment to improve conditions for the 387 million people living with diabetes today[3], and those at risk of developing diabetes tomorrow.  

Outside of the professional cycling team, Team Novo Nordisk devotes much effort to inspiring and empowering young people with diabetes to take control of their condition and reach their goals. Team Novo Nordisk supports a growing Development Team, a talented group of aspiring cyclists with diabetes who, themselves, train and race around the globe, with the aim of one day reaching the professional rank.

About Diabetes  

Diabetes (or diabetes mellitus) is a chronic, life-long metabolic disease. The condition develops when there is too much sugar in the blood due to the body being unable to produce or respond to the hormone, insulin, in the normal way.[4]

There are two main types of diabetes. In type 1 diabetes, the body's immune system destroys the cells that produce insulin. People with type 1 diabetes, therefore, need insulin injections for the rest of their lives. About 10% of all people with diabetes have type 1.[4]

Type 2 diabetes is where the body does not produce enough insulin, or the body's cells do not react to insulin. This is known as insulin resistance. The symptoms of type 2 diabetes can sometimes be controlled by exercise and eating a healthy diet and monitoring blood glucose levels, but if the condition gets worse over time, it may need to be managed by medication.[4]

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 39,700 people in 75 countries and markets its products in more than 180 countries. For more information, visit novonordisk.co.uk, Facebook, Twitter, LinkedIn, YouTube.  


References 

  1. Diabetes UK. Facts and stats. Available at: https://www.diabetes.org.uk/Documents/Position%20statements/Facts%20and%20stats%20June%202015.pdf. Accessed August 2015.
  2. Diabetes UK. State of the Nation: Challenges for 2015 and beyond. Available at: https://www.diabetes.org.uk/Documents/About%20Us/What%20we%20say/State%20of%20the%20nation%202014.pdf. Accessed August 2015.
  3. International Diabetes Federation. IDF Diabetes Atlas, 6th Edition, 2014 Update. Brussels, Belgium: International Diabetes Federation. Available at: http://www.idf.org/diabetesatlas/update-2014. Accessed: August 2015.
  4. NHS Choices. Diabetes introduction. Available at: http://www.nhs.uk/Conditions/Diabetes/Pages/Introduction.aspx. Accessed: August 2015.

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.